Where does Central Adelaide Local Health Network Incorporated rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Central Adelaide Local Health Network Incorporated ranks #28,374 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is Central Adelaide Local Health Network Incorporated's Innovation Score?

Central Adelaide Local Health Network Incorporated has an Innovation Score of 29.4 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Central Adelaide Local Health Network Incorporated's patent grant rate increasing or decreasing?

Central Adelaide Local Health Network Incorporated's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Central Adelaide Local Health Network Incorporated's patents?

Central Adelaide Local Health Network Incorporated's patents average 9.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Central Adelaide Local Health Network Incorporated

Q: How many patents does Central Adelaide Local Health Network Incorporated hold?

Central Adelaide Local Health Network Incorporated holds 9 US utility patents granted between 2017 and 2025, spanning 7 technology areas.

Q: What technology areas does Central Adelaide Local Health Network Incorporated focus on?

Central Adelaide Local Health Network Incorporated's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 7 patents. Grants appear in 7 CPC subclasses total.

Q: How is the Central Adelaide Local Health Network Incorporated patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Central ranks #28,374 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 7 technology areas.

#28,374
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.4/100): 9.1
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28374 · Foreign Corporation #28,374 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #28,374/49,997
PHOTO-FINISH Cellino Biotech
CPC-NARROW C12Q · 7 areas
INNOV-THIN 29.4/100
CLAIMS-PAR 9.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cellino Biotech, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Central Adelaide… · this assignee

29
3D Lighting… · lowest

7

What this shows Central's Innovation Score is 29.4/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Central's grants concentrate

Central Adelaide Local Health Network Incorporated is a focused PatentsView assignee: 7 CPC subclasses with 77.8% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2018. By volume, Central sits between Cellino Biotech, Inc. and Chapman University.

Central's three-year grant acceleration

Central Adelaide Local Health Network Incorporated shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cellino Biotech

9
Cellsec

9
Cellutech AB

9
Center Vue S p A

9
Centro de Investi…

9
Certona

9
Changsha Sinocare

9
Chapman University

9
Central Adelaide… ◀

9

What this shows Central holds 9 patents at rank #28,446, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Central

By rank, the assignees closest to #28,446 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Central's primary technology class.

Central's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Central Adelaide Local Health Network Incorporated patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	33.3%
2018	1	11.1%
2020	2	22.2%
2022	1	11.1%
2024	1	11.1%
2025partial year	1	11.1%

Which technologies does Central Adelaide Local Health Network Incorporated patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 7

C07K - Peptides 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 2

C07D - Heterocyclic Compounds 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#28,374

of 49,997 tracked assignees

Innovation Score

29.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Central Adelaide Local Health Network Incorporated's patent record in context - here's where to go next.

Central Adelaide Local Health Network Incorporated's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 77.8% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #28,374 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Central Adelaide Local Health Network Incorporated against Cellino Biotech, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.